Clinical Trial Modernization Act
Latest action · May 20, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 20, 2025
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Clinical Trial Modernization Act
This bill authorizes a grant program and provides certain exemptions to support the participation of individuals in clinical trials.
Specifically, the bill authorizes a grant program to support outreach, education, and recruitment efforts for clinical trials that may benefit certain underrepresented populations or communities in need, such as rural or tribal areas.
The bill also exempts from anti-kickback laws for federal health care programs (1) remuneration that is offered to cover participants' expenses to participate in clinical trials, (2) the provision of free digital health technologies to support participation of underrepresented populations in clinical trials, and (3) payment for participants' cost-sharing obligations in relation to clinical trials.
Finally, the bill exempts up to $2,000 in remuneration that is received for participating in a clinical trial from income tax.
Cosponsors 36
Members who signed on, in the order they did. Signatures ran from May 20, 2025 to Nov 10, 2026; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-TX | August Pfluger | Original | May 20, 2025 |
| R-AZ | Juan Ciscomani | Jun 4, 2025 | |
| D-TN | Steve Cohen | Jun 11, 2025 | |
| D-FL | Darren Soto | Jul 10, 2025 | |
| D-MA | Jake Auchincloss | Sep 2, 2025 | |
| R-NY | Michael Lawler | Aug 20, 2026 | |
| D-MA | Stephen F. Lynch | Aug 20, 2026 | |
| D-GA | Henry C. "Hank" Johnson, Jr. | Aug 31, 2026 | |
| D-NH | Maggie Goodlander | Sep 15, 2026 | |
| D-WI | Mark Pocan | Sep 15, 2026 | |
| R-TX | Randy K. Weber, Sr. | Sep 15, 2026 | |
| R-NJ | Thomas H. Kean, Jr. | Sep 15, 2026 | |
| R-IA | Ashley Hinson | Sep 24, 2026 | |
| D-MI | Debbie Dingell | Sep 24, 2026 | |
| D-CA | Gilbert Ray Cisneros, Jr. | Sep 24, 2026 | |
| D-OH | Greg Landsman | Sep 24, 2026 | |
| D-TX | Henry Cuellar | Sep 24, 2026 | |
| R-MI | Jack Bergman | Sep 24, 2026 | |
| R-TX | Jake Ellzey | Sep 24, 2026 | |
| D-AZ | Yassamin Ansari | Sep 24, 2026 | |
| D-CA | Zoe Lofgren | Sep 24, 2026 | |
| R-PA | Brian K. Fitzpatrick | Sep 28, 2026 | |
| D-DC | Eleanor Holmes Norton | Sep 28, 2026 | |
| D-MO | Emanuel Cleaver | Sep 28, 2026 | |
| D-OR | Janelle S. Bynum | Oct 6, 2026 | |
| R-PA | Lloyd Smucker | Oct 6, 2026 | |
| R-OH | Max L. Miller | Oct 6, 2026 | |
| D-MA | Seth Moulton | Oct 6, 2026 | |
| D-AL | Terri A. Sewell | Oct 6, 2026 | |
| D-MA | William R. Keating | Oct 6, 2026 | |
| R-TX | Dan Crenshaw | Nov 5, 2026 | |
| D-CT | Jahana Hayes | Nov 5, 2026 | |
| D-OH | Joyce Beatty | Nov 5, 2026 | |
| D-WA | Emily Randall | Nov 10, 2026 | |
| D-NY | Josh Riley | Nov 10, 2026 | |
| R-PA | Mike Kelly | Nov 10, 2026 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 20, 2025 |
| House | Ways and Means Committee | Referred May 20, 2025 |
Actions 2
Everything that happened, newest first.
- May 20, 2025Introduced in House
- May 20, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 85, May 20, 2025, page H2199.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 4440 | Clinical Trial Modernization Act | Related bill | Apr 29, 2026 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes.
- Short Title(s) as Introduced
- Clinical Trial Modernization Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- May 20, 2025Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
